Recent advances in data availability and breakthroughs in computational power have given scientists new opportunities to optimise the discovery, design and developability of biotherapeutics.
However, with their utility lacking comparatively behind the small molecule space, there remains an ever-present need to address current capabilities amongst the scientific and operational challenges that exist.
CDD for Biologics has been specifically designed to help biopharmaceutical companies define strategies to further adapt these tools, mitigate data availability issues and address computational-experimental challenges to add immediate value to their biologics pipelines.
This year, over 25 computational and experimental leaders have committed to present. Sharing the very latest insights into how these tools are being utilised to enhance cost-effectiveness, shorten biologics development timelines and accelerate program development.
To find out more download the full event here:
WHO ATTENDED CDD for Biologics 2017?